Your browser doesn't support javascript.
loading
Sepsis-Associated Encephalopathy: A Mini-Review of Inflammation in the Brain and Body.
Ito, Hiroshi; Hosomi, Sanae; Koyama, Yoshihisa; Matsumoto, Hisatake; Imamura, Yukio; Ogura, Hiroshi; Oda, Jun.
Afiliação
  • Ito H; Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Hosomi S; Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Koyama Y; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Matsumoto H; Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka, Japan.
  • Imamura Y; Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Ogura H; Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Oda J; Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Front Aging Neurosci ; 14: 912866, 2022.
Article em En | MEDLINE | ID: mdl-35711904
ABSTRACT
Sepsis is defined as a life-threatening multi-organ dysfunction triggered by an uncontrolled host response to infectious disease. Systemic inflammation elicited by sepsis can cause acute cerebral dysfunction, characterized by delirium, coma, and cognitive dysfunction, known as septic encephalopathy. Recent evidence has reported the underlying mechanisms of sepsis. However, the reasons for the development of inflammation and degeneration in some brain regions and the persistence of neuroinflammation remain unclear. This mini-review describes the pathophysiology of region-specific inflammation after sepsis-associated encephalopathy (SAE), clinical features, and future prospects for SAE treatment. The hippocampus is highly susceptible to inflammation, and studies that perform treatments with antibodies to cytokine receptors, such as interleukin-1ß, are in progress. Future development of clinically applicable therapies is expected.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article